Mometasone    (DrugBank: Mometasone)

2 diseases
IDDisease name (Link within this page)Number of trials
98Eosinophilic gastrointestinal disease2
162Pemphigoid1

98. Eosinophilic gastrointestinal disease    [ 128 clinical trials,   147 drugs,   (DrugBank: 40 drugs),   34 drug target genes,   132 drug target pathways]
Searched query = "Eosinophilic gastrointestinal disease", "Eosinophilic gastroenteritis", "Eosinophilic esophagitis", "Eosinophilic colitis", "Eosinophilic gastro-intestinal disorder", "EGID", "Neonatal food-protein induced enterocolitis", "N-FPIES"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 128 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2020-000082-16-NL
(EUCTR)
29/10/202003/09/2020A study to investigate the efficacy and tolerability of the drug ESO-101 in adult patients with inflammation of the esophagusA randomized, placebo-controlled, double-blind trial evaluating the efficacy, tolerability and safety of ESO-101 in adult patients with active eosinophilic esophagitis Active eosinophilic esophagitis
MedDRA version: 20.1;Level: PT;Classification code 10064212;Term: Eosinophilic oesophagitis;System Organ Class: 10017947 - Gastrointestinal disorders;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Name: ESO-101
Product Code: ESO-101
INN or Proposed INN: mometasone
Other descriptive name: MOMETASONE FUROATE
EsoCap AGNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
42Phase 2Spain;Germany;Netherlands;Switzerland
2NCT02113267
(ClinicalTrials.gov)
April 201410/4/2014Mometasone-furoate for Treatment of Eosinophilic Esophagitis - a Randomized Placebo Controlled Study.Treatment of Eosinophilic Esophagitis With Mometason Furoat Aerosol: a Randomised, Placebo-controled Phase II Study for Evaluation of Treatment Effect on Group Level Including Symtom QuestionnairesEosinophilic EsophagitisDrug: Mometasone furoate;Drug: PlaceboMogens BoveVastra Gotaland RegionTerminated18 YearsN/AAll40Phase 2Sweden

162. Pemphigoid    [ 70 clinical trials,   117 drugs,   (DrugBank: 46 drugs),   30 drug target genes,   128 drug target pathways]
Searched query = "Pemphigoid", "Epidermolysis bullosa acquisita"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 70 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04499235
(ClinicalTrials.gov)
January 30, 202031/7/2020A Study to Assess the Therapeutic Effect and Safety of Adjunctive AKST4290 in Subjects With Bullous PemphigoidDouble-Blind, Randomized, Placebo-Controlled Trial of AKST4290 for Adjunctive Treatment of Mild to Moderate Bullous PemphigoidPemphigoid, BullousDrug: Mometasone furoate;Drug: AKST4290;Drug: PlaceboAlkahest, Inc.NULLRecruiting60 Years95 YearsAll30Phase 2Germany